[HTML][HTML] Β-hydroxybutyrate: A crucial therapeutic target for diverse liver diseases
K Li, W Wang, J Wu, W Xiao - Biomedicine & Pharmacotherapy, 2023 - Elsevier
Abstract β-hydroxybutyrate (β-HB), the most abundant ketone body, is produced primarily in
the liver and acts as a substitute energy fuel to provide energy to extrahepatic tissues in the …
the liver and acts as a substitute energy fuel to provide energy to extrahepatic tissues in the …
Krüppel-like factor 15 in liver diseases: Insights into metabolic reprogramming
H Chen, LL Li, Y Du - Frontiers in Pharmacology, 2023 - frontiersin.org
Liver diseases, characterized by metabolic disorder, have become a global public health
problem with high morbidity and mortality. Krüppel-like factor 15 (KLF15) is a zinc-finger …
problem with high morbidity and mortality. Krüppel-like factor 15 (KLF15) is a zinc-finger …
Various types of fasting diet and possible benefits in nonalcoholic fatty liver: Mechanism of actions and literature update
ZS Mirrazavi, V Behrouz - Clinical Nutrition, 2024 - Elsevier
Non-alcoholic fatty liver disease (NAFLD) is one of the major causes of chronic liver injury,
affecting around one-fourth of the general population across the world. Several important …
affecting around one-fourth of the general population across the world. Several important …
[HTML][HTML] CRISPR/Cas9 genetic screens in hepatocellular carcinoma gene discovery
CH Chiu - Current Research in Biotechnology, 2023 - Elsevier
The clustered regularly interspaced short palindromic repeats (CRISPR)/CRISPR-
associated protein 9 (Cas9) system is a powerful gene editing tool originated from …
associated protein 9 (Cas9) system is a powerful gene editing tool originated from …